The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global hernia repair market reached a value of US$ 4.3 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit stable growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Hernia refers to a medical condition in which an organ or fatty tissue passes through a hole or a sensitive spot in the surrounding muscle or connective tissue. Inguinal, femoral, incisional, ventral, umbilical and hiatal hernias are some of the most common types that are usually caused by obesity, diarrhea, constipation and persistent coughing or sneezing. The condition is usually treated through various non-surgical and surgical methods, such as laparoscopic and open repair procedures. These procedures utilize various repair devices, including fixation devices (absorbable and non-absorbable tack), consumables (synthetic, biological, absorbable and non-absorbable mesh) and prosthetics. The devices aid in repairing and closing holes in the abdominal wall and preventing the reoccurrence of the hernia.
The increasing prevalence of hernia and other abdomen-related disorders is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population that is more susceptible to such ailments is also providing a boost to the market growth. In line with this, the rising awareness regarding the available treatment alternatives for hernia, including minimally invasive (MI) hernia repair devices, is also contributing to the market growth. Additionally, various product innovations, such as the development of biologic allograft mesh with improved efficiencies, are acting as another growth-inducing factor. In comparison to the traditionally used synthetic mesh, biologic mesh aids in minimizing post-surgery pain and offers a faster rate of recovery. Other factors, including the widespread adoption of robotics in surgical procedures, along with improving healthcare infrastructure across the globe, are projected to drive the market further.
Breakup by Product Type:
Breakup by Surgery Type:
Breakup by Hernia Type:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., BD (Becton, Dickinson and Company), Cook Medical Inc., CooperSurgical Inc., Ethicon Inc. (Johnson & Johnson), Herniamesh S.r.l., Lifecell Corporation (Allergan Plc), Maquet (Getinge), Medtronic Inc., Olympus Corporation, Via Surgical Ltd., W. L. Gore & Associates Inc., etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Surgery Type, Hernia Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., BD (Becton, Dickinson and Company), Cook Medical Inc., CooperSurgical Inc., Ethicon Inc. (Johnson & Johnson), Herniamesh S.r.l., Lifecell Corporation (Allergan Plc), Maquet (Getinge), Medtronic Inc., Olympus Corporation, Via Surgical Ltd. and W. L. Gore & Associates Inc|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at